Diabetes Mellitus, Type 2
Why trials studying Diabetes Mellitus, Type 2 stopped, in this sample of ClinicalTrials.gov.
31 stopped trials with a clear reason; 97% ended for non-scientific reasons.
| Reason | Trials | Share |
|---|---|---|
| logistics pi | 11 | 35% |
| slow accrual | 10 | 32% |
| funding business | 4 | 13% |
| regulatory | 3 | 10% |
| manufacturing supply | 2 | 6% |
| safety | 1 | 3% |
Trials
- Improving Relationships Using Motivational Interviewing
NCT05696964 · WITHDRAWN · funding business
“The research study was not funded.” - The ORTIZ Study: Optimising RASi Therapy With SZC
NCT04983979 · TERMINATED · slow accrual
“Lack of recruitment” - Heat Therapy in Patients With Type 2 Diabetes Mellitus
NCT05237219 · WITHDRAWN · logistics pi
“The human resources required to start enrollment were not available anymore.” - Diabetes Self-Management Education with Sleep Hygiene
NCT04420845 · WITHDRAWN · logistics pi
“The study was significantly delayed due to the COVID-19 pandemic. The PI has chosen not to conduct the study.” - Pilot RCT Feasibility Study: Cancer and T2D
NCT04468243 · TERMINATED · slow accrual
“Slow Accrual” - Effects of a Red/Gold/IR LED Combination Light on Reduction of Fat
NCT04525573 · WITHDRAWN · logistics pi
“Lost principal investigator. Have not picked up a new PI yet.” - Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM)
NCT04269655 · TERMINATED · logistics pi
“COVID-19” - Community Models for Hypertension and Diabetes Care for Refugees
NCT04229667 · TERMINATED · logistics pi
“As a result of COVID-19, the intervention design changed and an RCT was no longer an appropriate study design for evaluation.” - Integrated NCD Intervention in Rural Nepal
NCT04087369 · WITHDRAWN · funding business
“This study was withdrawn prior to participant enrollment due to a lack of external funding, dedicated resources, and shifting organizational priorities among research collaborators” - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
NCT04090242 · TERMINATED · logistics pi
“Enrollment halted prematurely due to the Covid-19 pandemic” - GDM Post Partum Screening
NCT03946631 · TERMINATED · logistics pi
“PI and Practice closed” - Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis.
NCT03921216 · SUSPENDED · logistics pi
“Covid19” - Evaluating the Glycemic Control wIth Vildagliptin and Metformin Combination Therapy.
NCT03577184 · WITHDRAWN · logistics pi
“Institutions issue” - The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.
NCT03152084 · TERMINATED · slow accrual
“Poor recruitment.” - Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia
NCT03132571 · TERMINATED · funding business
“Study discontinued due to funding.” - Dietary Polyphenols and Glycation in Renal Insufficiency
NCT02524938 · TERMINATED · slow accrual
“Failure to recruit due to human resourcing” - Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study
NCT02409238 · TERMINATED · logistics pi
“1. Limits of grant funding reached 2. A/Prof Ng Tze Pin (P.I. \& holder of NMRC Grant (CIRG12may033) funding this study) retired in Aug 2022. 3. Resignations of staff and collaborators especially over the 1st 2 years of the COVID-19 pandemic” - A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
NCT02106364 · WITHDRAWN · regulatory
“Lilly's decision to cancel this trial is due to regulatory uncertainty in China.” - Comparative Metabolomics in Diabetes Patients From Sri Lanka and Switzerland
NCT05787457 · TERMINATED · slow accrual
“Insufficient recruitment” - Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)
NCT03281083 · TERMINATED · slow accrual
“Difficult recruitment and end of funding.” - Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes
NCT02236481 · TERMINATED · funding business
“Decision of the Sponsor for Early Benefits” - An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes
NCT01817777 · TERMINATED · slow accrual
“It's no longer feasible to continue to recruit patients into the study as severe recruitment difficulties have been experienced since the study start” - Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers
NCT01725672 · TERMINATED · regulatory
“Due to changes in EMA guidelines on modified release dosage forms (Feb 2013; EMA/CHMP/EWP/280/96). The Part B formulation would not meet the new guidelines.” - Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition
NCT01081938 · TERMINATED · slow accrual
“Recruitment challenges” - Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting
NCT01079364 · TERMINATED · slow accrual
“Slow recruitment” - A Study of LY2599506 in Patients With Type 2 Diabetes
NCT01024244 · TERMINATED · safety
“Terminated due to nonclinical safety findings” - Two Pieces of Fruit to Type 2 Diabetics?
NCT01010594 · TERMINATED · logistics pi
“PI changed job and project was not economically viable and therefor terminated” - Medication in Early Diabetes (MED) Study
NCT00437970 · WITHDRAWN · manufacturing supply
“Unable to secure supply of the study medication” - Variation in Sulphonylurea Response in Type 2 Diabetes
NCT00738088 · TERMINATED · regulatory
“Following Regulator inspection in 2009, study terminated as inadequate approvals were in place” - A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks
NCT00427401 · TERMINATED · manufacturing supply
“This study was terminated May 7, 2007. The study stopped due to tablet formulation issues. No safety issues were involved in the termination decision.” - Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot Study
NCT00325910 · TERMINATED · slow accrual
“Insufficient study participants”
Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.